Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 412,612 | 352,299 | 553,074 | 641,755 | 567,045 |
| Marketable Securities | N/A | N/A | N/A | 60,358 | 311,869 |
| Receivables | 264,926 | 206,442 | 7,727 | 10,103 | N/A |
| Inventories | 81,404 | 146,362 | 85,714 | 16,286 | 0 |
| Other current assets | 11,644 | 22,408 | 36,658 | 70,677 | 26,878 |
| TOTAL | $788,954 | $766,331 | $719,523 | $824,047 | $917,192 |
| Non-Current Assets | |||||
| PPE Net | 2,952 | 4,345 | 6,148 | 6,177 | 6,803 |
| Other Non-Current Assets | 93,145 | 18,054 | 34,546 | 51,541 | 36,574 |
| TOTAL | $96,097 | $22,399 | $40,694 | $57,718 | $43,377 |
| Total Assets | $885,051 | $788,730 | $760,217 | $881,765 | $960,569 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 38,572 | 37,516 | 37,342 | 16,909 | 8,477 |
| Accrued Expenses | 140,184 | 127,806 | 95,139 | 103,239 | 111,935 |
| Other current liabilities | N/A | 75,830 | 29,504 | 7,584 | 4,230 |
| TOTAL | $185,509 | $247,593 | $167,610 | $131,847 | $128,327 |
| Non-Current Liabilities | |||||
| Long Term Debt | 359,489 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 111,514 | 346,616 | 422,735 | 551,256 | 627,685 |
| TOTAL | $471,003 | $346,616 | $422,735 | $551,256 | $627,685 |
| Total Liabilities | $656,512 | $594,209 | $590,345 | $683,103 | $756,012 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 125,516 | 120,582 | 111,291 | 97,731 | 80,375 |
| Common Shares | 12 | 12 | 11 | 10 | 8 |
| Retained earnings | -3,035,366 | -2,837,488 | -2,308,860 | -1,656,688 | -926,347 |
| Other shareholders' equity | -3,308 | -3,542 | -875 | -2,090 | -117 |
| TOTAL | $228,539 | $194,521 | $169,872 | $198,662 | $204,557 |
| Total Liabilities And Equity | $885,051 | $788,730 | $760,217 | $881,765 | $960,569 |